A 'pre-induction course' with non-cross-reacting cytostatic drugs for rapid tumour load reduction improves outcome in adult acute lymphoblastic leukaemia [2]

British Journal of Haematology

Volumn 138, Issue 2, 2007, Pages 275-277

  Daenen, Simon ^a   Van Imhoff, Gustaaf W ^a   De Wolf, Joost T M ^a   Vellenga, Edo ^a   Van Den Berg De Ruiter, Eva ^a   Kluin Nelemans, Hanneke C ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Acute lymphoblastic leukaemia; Allogeneic stem cell transplantation; Chemotherapy; Survival; Toxicity

Indexed keywords

ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; CYTOSTATIC AGENT; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; MERCAPTOPURINE; METHOTREXATE; MITOXANTRONE; PREDNISONE; VINCRISTINE; VINCRISTINE SULFATE;

ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ALLOGENEIC STEM CELL TRANSPLANTATION; B CELL LEUKEMIA; BONE MARROW; CANCER REGRESSION; CANCER RELAPSE; CANCER SURVIVAL; CEREBROSPINAL FLUID; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DRUG DOSE REDUCTION; FOLLOW UP; HUMAN; IMMUNOPHENOTYPING; KARYOTYPING; KIDNEY DYSFUNCTION; LETTER; LEUKOPENIA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; T CELL LEUKEMIA; THROMBOCYTOPENIA; UNSPECIFIED SIDE EFFECT; WASTING SYNDROME;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC AGENTS; CYTARABINE; DRUG THERAPY, COMBINATION; ETOPOSIDE; FEMALE; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE, L2; MALE; METHOTREXATE; MIDDLE AGED; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 34250881180     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2007.06645.x     Document Type: Letter

References (8)

1. Daenen, S., van Imhoff, G.W., van den Berg, E., de Kam, P.J., Haaxma-Reiche, H., Vellenga, E., Smit, J.W. Halie, R.M. (1998) Improved outcome of adult acute lymphoblastic leukaemia by moderately intensified chemotherapy which includes a ''pre-induction'' course for rapid tumour reduction: preliminary results on 66 patients. British Journal of Haematology, 100, 273 282.
2. Hoelzer, D., Gökbuget, N. Ottmann, O. (2002) Clinical management of adult ALL. Hematology (American Society of Hematology Education Program Book), pp. 162 168.
3. Kantarjian, H., Thomas, D., O'Brien, S., Cortes, J., Giles, F.J., Jeha, S., Bueso-Ramos, C.E., Pierce, S., Shan, J., Koller, C., Beran, M., Keating, M. Freireich, E.J. (2004) Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethason (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia. Cancer, 101, 2788 2801.
4. Larson, R.A., Dodge, R.K., Burns, C.P., Lee, E.J., Stone, R.M., Schulman, P., Duggan, D., Davey, F.R., Sobol, R.E., Frankel, S.R., Hooberman, A.L., Westbrook, C.A., Arthur, D.C., George, S.L., Bloomfield, C.D. Schiffer, C.A. (1995) A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: Cancer and Leukemia Group B study 881. Blood, 85, 2025 2037.
5. Linker, C., Damon, L., Ries, C. Navarro, W. (2002) Intensified and shortened cyclical chemotherapy for adult acute lymphoblastic leukemia. Journal of Clinical Oncology, 20, 2464 2471.
6. Ribera, J.M., Ortega, J.J., Oriol, A., Fontanillas, M., Hernandez-Rivas, J.M., Brunet, S., Garcia-Conde, J., Maldonado, J., Zuazu, J., Gardella, S., Besalduch, J., Leon, P., Macia, J., Domingo-Albos, A., Feliu, E. San Miguel, J.F. (1998) Late intensification chemotherapy has not improved the results of intensive chemotherapy in adult acute lymphoblastic leukemia. Results of a prospective multicenter randomized trial (PETHEMA ALL-89). Haematologica, 83, 222 230.
7. Sallan, S.E. (2006) Myths and Lessons from the adult/pediatric interface in acute lymphoblastic leukaemia. Hematology (American Society of Hematology Education Program Book). 128 132.
8. Thomas, D.A., Faderl, S., Cortes, J., O'Brien, S., Giles, F.J., Konblau, S.M., Garcia-Manero, O., Keating, M.J., Andreeff, M., Jeha, S., Beran, M., Verstovsek, S., Pierce, S., Letvak, L., Salvado, A., Champlin, R., Talpaz, M. Kantarjian, H. (2004) Treatment of Philadelphia chromosome-positive acute lymphocytic leukemia with Hyper-CVAD and imatinib mesylate. Blood, 103, 4396 4407.